Bladder Cancer, Metastatic

Also known as: Metastatic Bladder Cancer

Drug	Drug Name	Drug Description
DB01248	Docetaxel	A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
DB01229	Paclitaxel	A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer.

Drug	Drug Name	Target	Type
DB01248	Docetaxel	Apoptosis regulator Bcl-2	target
DB01248	Docetaxel	Tubulin beta-1 chain	target
DB01248	Docetaxel	Cytochrome P450 3A4	enzyme
DB01248	Docetaxel	Cytochrome P450 3A5	enzyme
DB01248	Docetaxel	Cytochrome P450 3A7	enzyme
DB01248	Docetaxel	P-glycoprotein 1	transporter
DB01248	Docetaxel	Multidrug resistance-associated protein 7	transporter
DB01248	Docetaxel	Cytochrome P450 1B1	enzyme
DB01248	Docetaxel	Microtubule-associated protein 2	target
DB01248	Docetaxel	Microtubule-associated protein 4	target
DB01248	Docetaxel	Microtubule-associated protein tau	target
DB01248	Docetaxel	Solute carrier organic anion transporter family member 1B3	transporter
DB01248	Docetaxel	Solute carrier family 22 member 7	transporter
DB01248	Docetaxel	ATP-binding cassette sub-family G member 2	transporter
DB01248	Docetaxel	Canalicular multispecific organic anion transporter 1	transporter
DB01248	Docetaxel	Multidrug resistance-associated protein 1	transporter
DB01248	Docetaxel	Nuclear receptor subfamily 1 group I member 2	target
DB01229	Paclitaxel	Apoptosis regulator Bcl-2	target
DB01229	Paclitaxel	Tubulin beta-1 chain	target
DB01229	Paclitaxel	Cytochrome P450 2C8	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A4	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A5	enzyme
DB01229	Paclitaxel	Cytochrome P450 3A7	enzyme
DB01229	Paclitaxel	Bile salt export pump	transporter
DB01229	Paclitaxel	P-glycoprotein 1	transporter
DB01229	Paclitaxel	Multidrug resistance-associated protein 1	transporter
DB01229	Paclitaxel	Multidrug resistance-associated protein 7	transporter
DB01229	Paclitaxel	Cytochrome P450 19A1	enzyme
DB01229	Paclitaxel	Cytochrome P450 1B1	enzyme
DB01229	Paclitaxel	Solute carrier organic anion transporter family member 1B3	transporter
DB01229	Paclitaxel	Nuclear receptor subfamily 1 group I member 2	target
DB01229	Paclitaxel	Microtubule-associated protein 4	target
DB01229	Paclitaxel	Microtubule-associated protein 2	target
DB01229	Paclitaxel	Microtubule-associated protein tau	target
DB01229	Paclitaxel	Canalicular multispecific organic anion transporter 1	transporter

Drug	Drug Name	Phase	Status	Count
DB11595	Atezolizumab	1	Recruiting	1
DB09035	Nivolumab	1	Completed	1
DB16409	Tiragolumab	1	Recruiting	1
DB11595	Atezolizumab	1 / 2	Active Not Recruiting	1
DB11945	Avelumab	1 / 2	Terminated	1
DB00515	Cisplatin	1 / 2	Active Not Recruiting	1
DB14873	Enadenotucirev	1 / 2	Completed	1
DB16168	Fluorocyclopentenylcytosine	1 / 2	Completed	1
DB00441	Gemcitabine	1 / 2	Active Not Recruiting	1
DB06094	Apatorsen	2	Completed	1
DB11595	Atezolizumab	2	Recruiting	1
DB11945	Avelumab	2	Terminated	1
DB00958	Carboplatin	2	Completed	1
DB00958	Carboplatin	2	Terminated	1
DB00515	Cisplatin	2	Completed	1
DB00515	Cisplatin	2	Terminated	1
DB11714	Durvalumab	2	Completed	1
DB00441	Gemcitabine	2	Completed	1
DB00441	Gemcitabine	2	Terminated	1
DB11771	Tremelimumab	2	Completed	1
DB15442	Trilaciclib	2	Terminated	1